Synthesis, structural and electrochemical properties of nickel(II) sulfamethazine complex with diethylenetriamine ligand.

In this study, [Ni(dien)2]⋅smz2⋅(Hsmz: sulfamethazine and dien: diethylenetriamine) complex has been synthesized and its crystal structure has been determined by X-ray diffraction technique. The title complex crystallizes in orthorhombic system with space group Pbnb [a=8.556(5), b=16.228(5), c=28.209(5)Å, V=3917(3)Å(3) and Z=4]. The nickel(II) ion has distorted octahedral coordination geometry. The metal atom, which rides on a crystallographic center of symmetry, is coordinated by six nitrogen atoms of two dien ligands to form a discrete [Ni(dien)2](2+) unit, which captures two sulfamethazine ions, each through intermolecular hydrogen bonds. The powder EPR spectrum of Cu(2+) doped Ni(II) complex was recorded at room temperature. The vibrational investigation has been carried out by considering the characteristic bands related to the functional groups of the complex. The electrochemical behavior of Ni(II) ions in the presence and in the absence of smz and dien were studied by square wave and cyclic voltammetry. A well-defined irreversible peak at -1.112V different from those of the Ni(II)-smz (-0.876V) and the Ni(II)-dien complex (-1.064V) was observed in the solution containing Ni(II) ions, which was attributed to the formation of the new mixed ligand complex of Ni(II) with smz and dien.

Sulfa drugs as inhibitors of carbonic anhydrase: new targets for the old drugs.

Sulfa drugs are well-known antibacterial agents containing N-substituted sulfonamide group on para position of aniline ring (NH2RSO2NHR'). In this study 2,4-dichloro-1,3,5-triazine derivatives of sulfa drugs, sulfamerazine (1b), sulfaquinoxaline (2b), sulfadiazine (3b), sulfadimidine (4b), and sulfachloropyrazine (5b) (1a-5a) were synthesized and characterized. Their carbonic anhydrase inhibition activity was evaluated against bovine cytosolic carbonic anhydrase isozyme II (bCA II). For the sake of comparison the CA inhibition activity of the parent sulfa drugs (1b-5b) was also evaluated. A significant increase in CA inhibition activity of sulfa drugs was observed upon substitution with 2,4-dichloro-1,3,5-triazine moiety. Molecular docking studies were carried out to highlight binding site interactions. ADME properties were calculated to evaluate drug likeness of the compounds.

Synthesis and anti-HIV activity of 4-[(1,2-dihydro-2-oxo-3H-indol-3-ylidene) amino]-N(4,6-dimethyl-2-pyrimidinyl)-benzene sulfonamide and its derivatives.

4-[(1,2-Dihydro-2-oxo-3H-indol-3-ylidene) amino]-N(4,6-dimethyl-2-pyrimidinyl)-benzene sulphonamide and its derivatives were synthesized by reaction of isatin and its derivatives with sulphadimidine. Their chemical structures have been confirmed by IR, (1)H NMR data and elemental analysis. Investigation of anti-HIV activity of compounds were tested against replication of HIV-1 (IIIB) and HIV-2 (ROD) strains in acutely infected MT-4 cells and the activity compared with standard azidothymidine. Among the compounds tested, 4-[(1,2-dihydro-2 oxo-3H-indol-3-ylidene)amino]-N(4,6-dimethyl-2-pyrimidinyl)-benzene sulphonamide and its N-acetyl derivative were the most active compounds.

Absorption of N4-D-glucopyranosylsulphamethazine by rat everted intestinal sacs.

Absorption of the N4-D-glucose conjugate of sulphamethazine (glucose-SMZ, 0.5 mM) by isolated everted sacs of the rat small intestine was studied at 37 degrees and pH 6.6. Phlorizin (0.5-2.0 mM) significantly reduced (P < 0.05) both mucosal and serosal transfer of glucose-SMZ and inhibition of mucosal transfer appeared to be concentration-dependent. Phloretin (0.5 mM) and removal of Na+ from the incubation medium also diminished absorption of glucose-SMZ. Furthermore, D-glucose (0.5 and 5.0 mM) inhibited mucosal and serosal transfer of the glycoside. The results suggest the D-glucose/Na+ cotransporter mediates absorption of glucose-SMZ from the small intestine of the rat. Thus, glucose-SMZ might be bioavailable from ingested tissues in which it is present.